Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
出版年份 2018 全文链接
标题
Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
作者
关键词
-
出版物
Frontiers in Physiology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-26
DOI
10.3389/fphys.2018.00452
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of Galectins in Tumors and in Clinical Immunotherapy
- (2018) Feng-Cheng Chou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study
- (2017) Tomoko Tadokoro et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Regulatory T Cell–Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9
- (2017) Shravan Madireddi et al. JOURNAL OF IMMUNOLOGY
- Prognostic value of tumoral expression of galectin-9 in gastric cancer
- (2017) Sang Il Choi et al. Turkish Journal of Gastroenterology
- Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
- (2017) Yidong Liu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- MicroRNA profiles during galectin‑9‑induced apoptosis of pancreatic cancer cells
- (2017) Ryoichi Okura et al. Oncology Letters
- Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature
- (2017) Sara M. Melief et al. Cancer Immunology Research
- PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
- (2017) Kostandinos Sideras et al. OncoImmunology
- The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
- (2017) Isabel Gonçalves Silva et al. EBioMedicine
- Galectin-9: An anticancer molecule for gallbladder carcinoma
- (2016) TOMOKO TADOKORO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Modes of invasion during tumour dissemination
- (2016) Pahini Pandya et al. Molecular Oncology
- Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway
- (2016) Yang Wang et al. PLoS One
- Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
- (2016) Andrée-Anne Grosset et al. Oncotarget
- Abstract A008: Discriminant function for predicting survival of lung adenocarcinoma patients developed by using immune parameters of PD-L1, Gal-9, and XAGE1 expression on tumor cells and T cell infiltration score
- (2016) Yoshihiro Ohue et al. Cancer Immunology Research
- Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
- (2015) KOJI FUJITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest
- (2015) KIYOYUKI KOBAYASHI et al. ONCOLOGY REPORTS
- Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
- (2015) Hangcheng Fu et al. TUMOR BIOLOGY
- Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
- (2014) K. Nagahara et al. JOURNAL OF IMMUNOLOGY
- Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
- (2014) Iris A. Schulkens et al. PLoS One
- Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
- (2013) Jing Jiang et al. PLoS One
- Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
- (2012) Zhao-Yang Zhang et al. Asian Pacific Journal of Cancer Prevention
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
- (2012) Valerie R. Wiersma et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Classifying collective cancer cell invasion
- (2012) Peter Friedl et al. NATURE CELL BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages
- (2011) Takeshi Kadowaki et al. CLINICAL IMMUNOLOGY
- Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
- (2010) T Kobayashi et al. LEUKEMIA
- Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
- (2010) J. Kuroda et al. MOLECULAR CANCER RESEARCH
- Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice
- (2008) Atsuya Nobumoto et al. CLINICAL IMMUNOLOGY
- Different roles of galectin-9 isoforms in modulating E-selectin expression and adhesion function in LoVo colon carcinoma cells
- (2008) Feng Zhang et al. MOLECULAR BIOLOGY REPORTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search